Trials / Completed
CompletedNCT02997111
PFA-100 Responsive to Effect of Energy Drinks on Platelet Function
Is the PFA-100 Responsive to the Effect of Energy Drinks on Platelet Function Changes?
- Status
- Completed
- Phase
- N/A
- Study type
- Interventional
- Enrollment
- 13 (actual)
- Sponsor
- St. Louis University · Academic / Other
- Sex
- All
- Age
- 18 Years – 35 Years
- Healthy volunteers
- Accepted
Summary
This study evaluates the responsiveness of the Platelet Function Analyzer (PFA-100) to the effect of energy drinks on platelet function. Participants' will have blood drawn prior to and 60 minutes after ingesting 250ml of a commercially available sugar-free energy drink.
Detailed description
Two previous studies have demonstrated increased platelet aggregation 60 minutes after drinking a commercially available sugar-free energy drink. These studies utilized traditional platelet function studies, such as light transmission aggregometry (LTA), where platelet function is examined while adding varying concentrations of a panel of agonist to platelets. These studies are technically difficult, time intensive studies requiring specialized laboratories. They are relatively non-physiologic and do not mimic platelet response to vessel wall damage. Other tests better represent the reactions to vessel wall damage, including the PFA-100, which measures platelet aggregation and adhesion under conditions of high shear. Overall, PFA-100 is less expensive, requires less technical skill, and is less time consuming than LTA. It has been utilized in bleeding disorders and is demonstrating promise as a marker of thrombophilia. PFA-100 has demonstrated sensitivity to drug and dietary effects. It has also shown differences in closure time between sedentary and athletic individuals PFA-100 has not been used to investigate the effect of energy drinks.
Conditions
Interventions
| Type | Name | Description |
|---|---|---|
| DEVICE | PFA-100 | The PFA-100 will be used to assess platelet function before and after energy drink consumption. |
Timeline
- Start date
- 2017-02-14
- Primary completion
- 2017-06-09
- Completion
- 2017-06-20
- First posted
- 2016-12-19
- Last updated
- 2017-06-22
Locations
1 site across 1 country: United States
Source: ClinicalTrials.gov record NCT02997111. Inclusion in this directory is not an endorsement.